Last update:

HIV & AIDS news

HIV & AIDS

Trial HIV vaccine triggers elusive and essential antibodies, pointing the way toward a successful vaccine

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

Medications

What is PrEP? Will it stop me getting HIV?

HIV prevention was allocated A$43.9 million over three years in this week's federal budget. Some $26m of this is for "PrEP" for people without access to Medicare.

HIV & AIDS

New research traces the spread of HIV in and from Indonesia

The HIV variant dominant in Indonesia was introduced from Thailand over multiple events. A Kobe University study traces where it came from and how it spread from there, offering possible insights into the development of treatments ...

HIV & AIDS

Group-based interventions address HIV stigma

Group-based interventions have the potential to address HIV-related stigma among adolescents living with the virus, finds a recent study from researchers at the Brown School at Washington University in St. Louis and Makerere ...

HIV & AIDS

Study highlights importance of early interventions to combat HIV

A study has compared the development of HIV reservoirs—locations in the body where the virus persists in a latent state—between patients who receive either early or late medical interventions. The findings highlight the ...

HIV & AIDS

Visa rules jeopardize HIV management, study finds

A Monash University sexual health expert has warned that an unintended consequence of Australia's migration rules could compromise Australia's goal to end the HIV epidemic by 2030.

HIV & AIDS

Perinatal transmission of HIV can lead to cognitive deficits

Perinatal transmission of HIV to newborns is associated with serious cognitive deficits as children grow older, according to a detailed analysis of 35 studies conducted by Georgetown University Medical Center neuroscientists. ...

HIV & AIDS

Researchers identify novel factor in HIV transmission

University of Virginia School of Medicine researchers have found long-sought answers to questions about HIV transmission, and those findings could lead to new ways to prevent the disease's spread.

HIV & AIDS

Unlocking the mechanisms of HIV in preclinical research

Mayo Clinic researchers have unraveled the molecular mechanisms that affect which cells infected with human immunodeficiency virus (HIV) die and which survive, a discovery heralded as a step toward eliminating all HIV-infected ...

HIV & AIDS

Higher viral load during HIV infection can shape viral evolution

A new paper in Molecular Biology and Evolution finds that HIV populations in people with higher viral loads also have higher rates of viral recombination. In effect, the more HIV in the blood, the easier it is for the virus ...

HIV & AIDS

Expert discusses making HIV vaccines more powerful

An MIT research team led by Professor Darrell Irvine has developed a novel kind of vaccine adjuvant: A nanoparticle that can help to stimulate the immune system to generate a stronger response to a vaccine. These nanoparticles ...

HIV & AIDS

The quest to conquer latent HIV and end the AIDS pandemic

A 36-year-old Brazilian man made headlines around the world in 2020 for being the first person to be putatively cured of human immunodeficiency virus (HIV) using an easily accessible and well-tolerated drug cocktail.

HIV & AIDS

Study finds changing distribution of HIV-1 subtypes in Sweden

A new study has shown that the distribution of HIV-1 subtypes in Sweden has changed a lot since the beginning of the AIDS epidemic. This is largely due to the migration of already infected people to Sweden. The study focused ...